GMR Solutions Inc.(GMRS)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 6 days
PROFIT SINCE LAST BUY
-7.23% ▼
LAST CLOSE
$11.54
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for GMRS

11/13/2026: GMRS (1-star) has a low Upturn Star Rating. Not recommended to BUY.

GMR Solutions Inc. is a healthcare services company specializing in out-of-hospital medical care, emergency 911 dispatch, and transport solutions. The company's primary strengths lie in its essential infrastructure role and resilient municipal contracts, supported by recent debt reduction initiatives that have improved balance sheet health. Its core growth story centers on expanding mobile integrated healthcare offerings and deepening partnerships with major health systems. However, key risks include persistent labor market pressures for emergency personnel and exposure to government reimbursement policies. The stock is best suited for growth-oriented investors willing to monitor execution milestones and labor cost trends.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fit while signal remains positiveThe company is scaling its out-of-hospital clinical services and expanding municipal contract footprints.
Momentum investorStrong fit while signal remains positiveRecent positive earnings surprises and post-IPO trading activity support conditional momentum interest.
Value investorMixed fitCurrent valuation multiples require ongoing proof of sustained margin expansion following debt restructuring.
Dividend investorWeak fitGMR Solutions currently retains earnings to fund growth and pay down debt rather than distributing dividends.
Low-risk investorMixed fitWhile essential healthcare demand is defensive, post-IPO volatility and labor cost pressures introduce moderate risk.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highThe stock has experienced notable price swings following its recent public offering.
Valuation riskMediumValuation levels demand continuous earnings beats to justify current trading multiples.
Competition risk (labor and service market competition)HighAttracting and retaining qualified medical personnel remains a persistent operational challenge.
Business qualityStrongThe company provides essential, mission-critical healthcare transport infrastructure with resilient secular demand.
Dividend incomeLow / noneNo dividend is currently paid as capital is directed toward debt reduction.
Execution riskMediumManagement must successfully execute debt refinancing and integrate regional service expansions.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 769.70M USD
Price to earnings Ratio -
1Y Target Price 18.38
Price to earnings Ratio -
1Y Target Price 18.38
Volume (30-day avg) 990.3K shares
Beta -
52 Weeks Range 9.00 - 15.98
Updated Date 11/15/2026
52 Weeks Range 9.00 - 15.98
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) -3.09

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Care Facilities

BUY participation
88.9%
Active BUY / eligible
8 / 9
30-Day BUY Count Change
+6

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Downtrend
PRICE PATH

Downtrend

The stock has experienced a sustained decline in price over recent periods.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type Stock
Historic Profit -22.06%
Avg. Invested days 10
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
GMRS receives a 4-star rating, supported by solid company fundamentals, solid quantitative characteristics, and solid analyst coverage. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
GMRS has solid overall fundamentals (4 stars), with moderate financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, strong earnings growth (+910.5%) and solid cash generation (FCF margin 6.7%) are partially offset by slightly negative revenue growth (-4.0%), soft profitability (net margin 3.6%).

Financial Health Rating

★★★★★
GMRS's financial health is supported by solid cash strength, including free-cash-flow generation (6.7% of revenue). Profitability is moderate (3 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is GMRS's strongest growth driver at +1807.7% FY2025 versus FY2024 (strong, 5 stars). By comparison, earnings growth (+910.5%, strong) is also strong, while revenue growth (-4.0%, slightly negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 82.2% and approximately 62.9% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 6.57% supports management-shareholder alignment.

Top 5 Institutional Investors

Kohlberg Kravis Roberts & Co LP 22.17%
North Peak Capital Management, LLC 7.63%
FMR Inc 5.04%
Citadel Advisors Llc 4.78%
Amvescap Plc. 4.63%

Unit Economics (Per $1K Revenue)

★★★★★
GMRS generates approximately $389 of gross profit, $144 of operating income, and $67 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Moderate margins and solid cash conversion support a 3-star rating, while capital efficiency is moderate.

Economic Dimensions

★★★★★
Effective Tax Rate: 34.85%

Quantitative Style Profile

★★★★★
GMRS has a high-quality, liquid, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedQuality TiltLow VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Emergent Medical Services911 emergency dispatch, rapid response, and urgent municipal ambulance operations.Steady core revenue generated from mandatory emergency response services.
Non-Emergent Medical TransportScheduled inter-facility transfers, specialized patient mobility, and routine clinical transit.Reliable recurring volume tied to ongoing hospital and health system transfers.
Disaster Response & Federal ContractsLarge-scale emergency deployments, standby event coverage, and federal agency support.High-impact supplemental contracts that bolster top-line growth during major events.

Earnings Date

Report Date 2026-11-09
When After Market
Estimate 0.47
Actual 0.64

Profitability

Profit Margin 3.8%
Operating Margin (TTM) 12.33%

Management Effectiveness

Return on Assets (TTM) 7.24%
Return on Equity (TTM) 25.54%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 4.99B
Price to Sales(TTM) 0.13
Enterprise Value 4.99B
Price to Sales(TTM) 0.13
Enterprise Value to Revenue 0.84
Enterprise Value to EBITDA 4.99
Shares Outstanding 66.70M
Shares Floating 41.96M
Shares Outstanding 66.70M
Shares Floating 41.96M
Percent Insiders 6.57
Percent Institutions 82.2

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.